You are here

Article info

Article menu
Download PDFPDF
Review
Denosumab (XGEVA): assessment from a pharmacist's perspective

Authors

  1. Correspondence to Dr Irene Krämer, Department of Pharmacy, University Medical Center, Johannes Gutenberg-University Mainz, 55131 Mainz, Germany; Irene.Kraemer{at}unimedizin-mainz.de
View Full Text

Citation

Krämer I
Denosumab (XGEVA): assessment from a pharmacist's perspective
European Journal of Hospital Pharmacy 2014;21:175-180.

Publication history

  • Received June 25, 2013
  • Revised August 8, 2013
  • Accepted October 21, 2013
  • First published November 18, 2013.
Online issue publication 
August 30, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions